RAPID ACCESS TO INTERVENTION DEVELOPMENT - ADDENDUM

Release Date:  December 15, 1998

P.T.

National Cancer Institute

In the May 11, 1998 issue of the NIH Guide for Grants and Contracts, the National
Cancer Institute (NCI) announced a new initiative: Rapid Access to Intervention
Development (RAID).  The purpose of this Notice is to announce two changes to the
program, effective immediately:  1) academic investigators now may have
collaborations with small business partners and still qualify for RAID funding;
and, 2) a maximum of two distinct requests for support per investigator can be
submitted per receipt date.  The following is a brief overview of the RAID
program, with a link to the RAID web site.

RAID will make available to academic investigators the preclinical development
contract resources of NCI's Developmental Therapeutics Program.  The goal of RAID
is the rapid movement of novel molecules and concepts from the laboratory to the
clinic for proof-of-principle clinical trials.  RAID will assist investigators
who submit successful requests by providing any (or all) of the pre-clinical
developmental requirement for clinical translation.  These include, for example,
production, bulk supply, GMP manufacturing, formulation, and toxicology. 
Suitable types of agents for RAID include small molecules, biologics, or
vaccines.  For more information, visit the web site,
http://dtp.nci.nih.gov/docs/raid/raid_index.html. 

Request for RAID resources are to be submitted as described in the web site. 
Written requests will be evaluated by a specially constituted RAID panel,
consisting of selected NCI staff and outside experts from academia and industry. 
There will be two receipt dates per year, February 1, and August 1, with all
materials submitted directly to the office listed under INQUIRIES.

INQUIRIES

Inquiries are encouraged, and the opportunity to clarify issues or questions is
welcome.  Inquiries may be directed to:

RAID
Developmental Therapeutics Program
National Cancer Institute
6130 Executive Boulevard, Suite 843
Bethesda, MD  20892
Rockville, MD  20852 (for express/courier service)
Telephone:  (301) 496-8720
FAX:  (301) 402-0831
Email:  sausville@dtpax2.ncifcrf.gov

Return to Volume Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.